Technology-special-listing companies on South Korea's KOSDAQ market face increased burden as delisting criteria have been strengthened, according to E-Daily. These companies, which gain listing approval based on future growth potential rather than immediate profitability, now confront market capitalization management requirements that may distract from research and development efforts. The regulatory change affects firms that are exempt from revenue shortfall or continuing business loss criteria for a specified period post-listing, raising industry concerns about balancing compliance with innovation priorities.
KOSDAQ Strengthens Delisting Criteria for Listed Companies
The KOSDAQ market has implemented strengthened delisting criteria that increase regulatory requirements for listed companies. Technology-special-listing companies, which receive listing approval through an exceptional process recognizing future growth potential rather than current earnings, previously enjoyed exemptions from certain financial performance standards during an initial post-listing period. The new criteria introduce market capitalization thresholds that apply alongside existing exemptions for revenue shortfalls and continuing business losses.
Technology-Special-Listing Companies Face Market Cap Management Requirements
Companies that secured KOSDAQ listings through the technology-special-listing process now face market capitalization management obligations during periods when they should prioritize research and development and commercialization activities. These firms, which include biotech and other technology-focused enterprises, obtained listings based on assessments of future growth potential rather than immediate profitability metrics. The strengthened delisting criteria add market cap maintenance requirements to the operational challenges these companies already navigate during their development phases.
Industry Raises Concerns About R&D Focus
The strengthened criteria have generated concerns within the technology and biotech sectors about the impact on innovation activities. Companies that received special listing approval based on growth potential face the challenge of maintaining market capitalization levels while simultaneously investing in research and development and advancing commercialization efforts. The regulatory change introduces an additional management consideration during the critical period when these firms focus on transitioning from development to revenue generation.
FAQ
What are technology-special-listing companies on KOSDAQ?
Technology-special-listing companies are firms that receive KOSDAQ listing approval based on future growth potential rather than immediate profitability. These companies are exempt from revenue shortfall or continuing business loss criteria for a certain period after listing.
Why do strengthened KOSDAQ delisting criteria affect technology companies?
The strengthened delisting criteria introduce market capitalization management requirements for technology-special-listing companies during periods when they need to focus on research and development and commercialization. This adds operational burden during critical development phases when these firms prioritize innovation over immediate financial performance.
